ÂÜÀòÂÒÂ×

A 20-year veteran of the medical device and pharmaceutical industries, Dan most recently was Chief Commercial Officer for Neuronetics from 2018 to 2020. Following a successful IPO in 2018, Dan grew the commercial organization over 18 months to secure the company’s market leadership within the category. Before Neuronetics, he held senior commercial roles at JADAK, Zimmer Biomet, Medtronic and Fleet Laboratories. Dan earned his bachelor’s degree in finance and marketing from American University and his MBA from Southern Illinois University at Carbondale.